Erythropoietin regulates tumour growth of human malignancies

Carcinogenesis

Volumn 24, Issue 6, 2003, Pages 1021-1029

  Yasuda, Yashiko ^a   Fujita, Yoshihiko ^a   Matsuo, Takuya ^a   Koinuma, Satoshi ^a   Hara, Satoshi ^a   Tazaki, Akira ^a   Onozaki, Mie ^a   Hashimoto, Mitsuhiro ^b   Musha, Terunaga ^c   Ogawa, Kazuhiro ^d   Fujita, Hiroyoshi ^d   Nakamura, Yukio ^c   Shiozaki, Hitoshi ^a   Utsumi, Hiroshi ^b  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; PEPTIDE; RECEPTOR BLOCKING AGENT; STAT5 PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL SURVIVAL; CELL TRANSPLANTATION; CHORIOCARCINOMA; CONTROLLED STUDY; DRUG TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; MELANOMA; MOUSE; NONHUMAN; NUDE MOUSE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; UTERUS CANCER; XENOGRAFT;

EID: 0037479926     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgg060     Document Type: Review

References (46)

1. Koury,M.J. and Bondurant,M.C. (1990) Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science, 248, 378-381.
2. Kranz,S.B. (1991) Erythropoietin. Blood, 77, 419-434.
3. Jelkmann,W. (1992) Erythropoietin: structure, control of production, and function. Physiol. Rev., 72, 449-489.
4. Youssoufian,H., Longmore,G., Neumann,D., Yoshimura,A. and Lodish,H.F. (1993) Structure, function, and activation of the erythropoietin receptor. Blood, 81, 2223-2236.
5. Ihle,J.N. (1995) Cytokine receptor signalling. Nature, 377, 591-594.
6. Broudy,V.C., Lin,N., Brice,M., Nakamoto,B. and Papayannopoulou,T. (1991) Erythropoietin receptor characteristics on primary human erythroid cells. Blood, 77, 2583-2590.
7. Wickrema,A., Krantz,S.B., Winkelmann,J.C. and Bondurant,M.C. (1992) Differentiation and erythropoietin receptor gene expression in human erythroid progenitor cells. Blood, 80, 1940-1949.
8. Schmit,R.M., Bruyns,E. and Snodgrass,H. (1991) Haematopoietic development of embryonic stem cells in vitro; cytokine and receptor gene expression. Genes Dev., 5, 728-740.
9. Yasuda,Y., Nagao,M., Okano,M., Masuda,S., Sasaki,R., Konishi,H. and Tanimura,T. (1993) Localization of erythropoietin and erythropoietin-receptor in postimplantation mouse embryos. Dev. Growth Differ., 35, 711-722.
10. Masuda,S., Nagao,M., Takahata, K., Konishi,Y., Gallyas,F. Jr., Tabira,T. and Sasaki,R. (1993) Functional erythropoietin receptor of the cells with neural characteristics: comparison with receptor properties of erythroid cells. J. Biol. Chem., 268, 11208-11216.
11. Masuda,S., Okano,M., Yamagishi,K., Nagao,M., Ueda,M. and Sasaki,R. (1994) A novel site of erythropoietin production: oxygen-dependent production in cultured rat astrocytes. J. Biol. Chem., 269, 19488-19493.
12. Marti,H.H., Wenger,R.H., Rivas,L.A., Straumann,U., Digicaylioglu,M., Henn,V., Yonekawa,Y., Bauer,C. and Gassmann,M. (1996) Erythropoietin gene expression in human, monkey and murine brain. Eur. J. Neurosci., 8, 666-676.
13. Morishita,E., Masuda,S., Nagao,M., Yasuda,Y. and Sasaki,R. (1997) Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience, 76, 105-116.
14. Yasuda,Y., Masuda,S., Chikuma,M., Inoue,K., Nagao,M. and Sasaki,R. (1998) Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis. J. Biol. Chem., 273, 25381-25387.
15. Yasuda,Y., Fujita,Y., Musha,J., Tanaka,H., Shiokawa,S., Nakamatsu,K., Mori,S., Matsuo,T. and Nakamura,Y. (2001) Expression of erythropoietin in human female reproductive organs. Mol. Cell Dev., 106, 215-222.
16. Yasuda,Y., Fujita,Y., Masuda,S., Musha,J., Ueda,K., Tanaka,H., Fujita,H., Matsuo,T., Nagao,M., Sasaki,R. and Nakamura,Y. (2002) Erythropoietin is involved in growth and angiogenesis in malignant tumours of female reproductive organs. Carcinogenesis, 23, 1797-1805.
17. Anagnostou,A., Liu,Z., Steiner,M., Chin,K., Lee,E.S., Kessimian,N. and Noguchi,C.T. (1994) Erythropoietin receptor mRNA expression in human endothelial cells. Proc. Natl Acad. Sci. USA, 91, 3974-3978.
18. Yamaji,R., Okada,T., Moriya,M., Naito,M., Tsuruo,T., Miyatake,K. and Nakano,Y. (1996) Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur. J. Biochem., 239, 494-500.
19. Sakanaka,M., Wen,T.-C., Matsuda,S., Masuda,S., Morishita,E., Nagao,M. and Sasaki,R. (1998) In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl Acad. Sci. USA, 95, 4635-4640.
20. Sadamoto,Y., Igase,K., Sakanaka,M., Sato,K., Otsuka,H., Sakaki,S., Masuda,S. and Sasaki,R. (1998) Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem. Biophys. Res. Commun., 253, 26-32.
21. Yu,X., Shacka,J.J., Eells,J.B. et al. (2002) Erythropoietin receptor signalling is required for normal brain development. Development, 129, 505-516.
22. Smenza,G.L. and Wang,G.U. (1992) A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell Biol., 12, 5447-5454.
23. Bunn,H.F. and Poyton,R.O. (1996) Oxygen sensing and molecular adaptation to hypoxia. Physiol. Rev., 76, 839-885.
24. Yasuda,Y., Musha,T., Tanaka,H. et al. (2001) Inhibition of erythropoietin signalling destroys xenografts of ovarian and uterine cancers in nude mice. Br. J. Cancer, 84, 836-843.
25. Hasumi,K., Sakamoto,G., Sugano,H., Kasuga,T. and Masubuchi,K. (1978) Primary malignant melanoma of the vagina: study of four autopsy cases ultrastructural findings. Cancer, 42, 2675-2686.
26. Utsumi,H. and Elkind,M.M. (1993) Human melanoma cells: relationship between their radiosensitivity and the repair of potentially lethal damage. Radiat. Oncol. Invest., 1, 29-33.
27. Goldberg,M.A., Allison,G.C., Cunningham,J.M. and Bunn,F. (1983) The regulated expression of erythropoietin by two hepatoma cell lines. Proc. Natl Acad. Sci. USA, 80, 6269-6293.
28. Komatsu,N. and Fujita,H. (1993) Induced megakaryocytic maturation of the human leukemic cell line UT-7 results in down-modulation of erythropoietic receptor gene expression. Cancer Res., 53, 1156-1161.
29. Höckel,M., Vorndran,B., Schlenger,K., Baußmann,E. and Knapstein,P.G. (1993) Tumour oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix. Gynecol. Oncol., 51, 141-149.
30. Goto,M., Murakami,A., Akai,K., Kawanishi,G., Ueda,M., Chiba,H. and Sasaki,R. (1989) Characterization and use of monoclonal antibodies directed against human erythropoietin that recognize different antigenic determinants. Blood, 74, 1415-1423.
31. Buettner,R., Mora,L.B. and Jove,K. (2002) Activated STAT signaling in human tumours provides novel molecular targets for therapeutic intervention. Clin. Cancer Res., 8, 945-954.
32. Johnson,D.L., Farrell,F.X., Barbone,F.P. et al. (1998) Identification of a 13 amid acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMP1. Biochemistry, 37, 3699-3710.
33. Trimble,M., Caro,J., Talalla,A. and Brain,M. (1991) Secondary erythrocytosis due to a cerebellar hemangioblastoma: demonstration of erythropoietin mRNA in the tumor. Blood, 78, 599-601.
34. Da Silva,J.-L., Lacombe,C., Bruneval,N., Casadavall,N., Leporrier,M., Camilleri,J-P., Bariety,J., Tambourin,P. and Varet,B. (1990) Tumor cells are the site of erythropoietin synthesis in human renal cancers associated with polycythemia. Blood, 75, 577-582.
35. Koury,S.T., Bondurant,M.C. and Koury,M.J. (1988) Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization. Blood, 71, 524-527.
36. Westenfelder,C. and Baranowski,R.L. (2000) Erythropoietin stimulates proliferation of human renal carcinoma cells. Kidney Int., 58, 647-657.
37. Katsuoka,Y., McGonigle,R., Rege,A.B., Beckman,B. and Fisher,J.W. (1983) Erythropoietin production in human renal carcinoma cells passaged in nude mice and in tissue culture. Gann, 74, 534-541.
38. Hood,J.D., Bednarski,M., Frausto,R., Guccione,S., Reisfeld,R.A., Xiang,R. and Cheresh,D.A. (2002) Tumor regression by targeted gene delivery to the neovasculature. Science, 296, 2404-2407.
39. Haller,H., Christel,C., Dannenberg,L., Thiele,P., Lindschau,C. and Luft,F.C. (1996) Signal transduction of erythropoietin in endothelial cells. Kidney Int., 50, 481-488.
40. Carroll,M.P., Spivak,J.L., McMahon,M., Weich,N., Rapp,U.R. and May,W.S. (1991) Erythropoietin induces Raf-1 activation and Raf-1 is required for erythropoietin-mediated proliferation. J. Biol. Chem., 266, 14964-14969.
41. Gobert,S., Duprez,V., Lacombe,C., Gisselbrecht,S. and Mayeux,P. (1995) The signal transduction pathway of erythropoietin involves three forms of mitogen-activated protein (MAP) kinase in UT7 erythroleukemia cells. Eur. J. Biochem., 234, 75-83.
42. Zhong,H., De Marzo,A.M., Laughner,E., Lim,M., Hilton,D.A., Zagzag,D., Buechler,P., Isaacs,W.B., Semenza,G.L. and Simons,J.W. (1999) Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res., 59, 5830-5835.
43. Ryan,H.E., Lo,J. and Johnson,R.S. (1998) HIF-1 is required for solid tumour formation and embryonic vascularization. EMBO J., 17, 3005-3015.
44. Carmeliet,P., Dor,Y., Herbert,J.-M. et al. (1998) Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature, 394, 486-490.
45. Hou,Q. and Gorski,J. (1993) Estrogen receptor and progesterone receptor genes are expressed differentially in mouse embryos during preimplantation development. Proc. Natl Acad. Sci. USA, 90, 9460-9464.
46. Losordo,D.W. and Isner,J.M. (2001) Estrogen and angiogenesis: a review. Arterioscler. Thromb. Vasc. Biol., 21, 6-12.